Page 26 - Query Get News Today

Cognitive impairment was more severe in hospitalized COVID-19 patients compared with those with other illnesses who required hospitalization, according to a study published in JAMA Psychiatry. “Several disease mechanisms play a role in the development of neuropsychiatric illness during and after COVID-19,” Vardan Nersesjan, MD, of Copenhagen University Hospital in Denmark, and

Twins conceived through assisted reproductive technology or fertility-enhancing drugs were more likely to have adverse neonatal outcomes compared with those who were conceived spontaneously.

Pregnant women in Oregon are avoiding the hospital for their birthing plans and turning to birthing centers or giving birth at home, likely due to the COVID-19 pandemic, according to a study in American Journal of Obstetrics & Gynecology.

BOSTON — Improvement in plaque psoriasis itch and severity, including in intertriginous areas, was significant in patients treated with roflumilast, according to a poster presented at the American Academy of Dermatology Annual Meeting. “Roflumilast is a nonsteroid, phosphodiesterase-4 inhibitor, so it has a very benign mechanism of action,” Mark G. Lebwohl, MD, dean for clinical

Routinely ordering mycobacterial cultures for patients with periprosthetic joint infections is not cost-effective and testing is not necessary in most cases, according to a study.

Firefighters who responded to a higher number of fires per year had a significantly greater risk for developing atrial fibrillation than those who responded to fewer fires, according to a recent study.

NEW ORLEANS – Having an underperforming website is one of the top 10 marketing mistakes optometric practices make, according to Kristin Choryan, ABOC, here at SECO 2022.

Steven A. Rosenberg, MD, PhD, FAACR, will receive this year’s Pezcoller Foundation-American Association of Cancer Research International Award for Extraordinary Achievement in Cancer Research.The award recognizes a scientist who has made a major scientific discovery in basic or translational cancer research, remains active in cancer research, and is conducting ongoing work that offers

In patients with ACS, the PCSK9 inhibitor alirocumab did not impact the development of atrial fibrillation compared with placebo, according to new data from the ODYSSEY Outcomes trial.While history of AF conferred greater risk for major adverse CV events during follow-up, the risk did not vary by assignment to alirocumab (Praluent, Sanofi/Regeneron) or placebo, according to the researchers.

Krishna Komanduri, MD, has been appointed division chief of hematology-oncology at UCSF Health.Komanduri, recognized for his expertise in the fields of cellular immunotherapy and transplantation, also will serve as physician-in-chief of Helen Diller Family Comprehensive Cancer Center and clinical director of UCSF Living Therapeutics Initiative.